Augmented betamethasone 0.0005 MG/MG Topical Ointment [Diprolene]
Augmented betamethasone
RxCUI: 848200
What the CMS Formulary Data Shows for Augmented betamethasone 0.0005 MG/MG Topical Ointment [Diprolene]
Per the CMS 2026 Part D formulary file, Augmented betamethasone 0.0005 MG/MG Topical Ointment [Diprolene] (RxNorm concept RXCUI 848200, generic name Augmented betamethasone) appears on 1 distinct formulary file spanning 2 Medicare Part D plan offerings - 0% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 1, with a cross-plan average of Tier 1.
Real-world access to Augmented betamethasone 0.0005 MG/MG Topical Ointment [Diprolene] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 100% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 17 Part D beneficiaries filled Augmented betamethasone 0.0005 MG/MG Topical Ointment [Diprolene] in 2023, with total plan-and-beneficiary spending of $12,001 and an average per-beneficiary annual cost of $705.96. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry Augmented betamethasone 0.0005 MG/MG Topical Ointment [Diprolene] today.
Coverage Details
- Formularies covering
- 1
- Plans covering
- 2
- Coverage rate
- 0%
- Tier range
- Tier 1, Preferred Generic
- Average tier
- Tier 1, Preferred Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 100% of formularies
2023 Medicare Spending
- Beneficiaries
- 17
- Total spending
- $12,001
- Avg per beneficiary
- $705.96
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering Augmented betamethasone 0.0005 MG/MG Topical Ointment [Diprolene]
2 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Hamaspik Medicare Choice (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $0 | NY |
| Hamaspik Medicare Select (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $34.50 | NY |
Frequently Asked Questions
Is Augmented betamethasone 0.0005 MG/MG Topical Ointment [Diprolene] covered by Medicare Part D?
Yes, Augmented betamethasone 0.0005 MG/MG Topical Ointment [Diprolene] is covered by 2 Medicare Part D plans (0% of all Part D formularies).
What tier is Augmented betamethasone 0.0005 MG/MG Topical Ointment [Diprolene] on Medicare Part D plans?
Augmented betamethasone 0.0005 MG/MG Topical Ointment [Diprolene] averages Tier 1 across Part D plans, ranging from Tier 1 to Tier 1.
Does Augmented betamethasone 0.0005 MG/MG Topical Ointment [Diprolene] require prior authorization?
0% of Part D formularies require prior authorization for Augmented betamethasone 0.0005 MG/MG Topical Ointment [Diprolene]. Step therapy: 0%. Quantity limits: 100%.
How much does Medicare spend on Augmented betamethasone 0.0005 MG/MG Topical Ointment [Diprolene]?
In 2023, total Medicare Part D spending on Augmented betamethasone 0.0005 MG/MG Topical Ointment [Diprolene] was $12,001, covering 17 beneficiaries. The average spend per beneficiary was $705.96.
Read our methodology - how this data is sourced, computed, and verified.